The Latest Cardiac and Vascular News
Landmark collaboration with Caristo Diagnostics positions NCH at the forefront of preventive cardiology NCH cardiologists to present collaboration plans at American Heart Association 2025 Scientific Sessions on Nov. 8 NAPLES, Fla. and STAMFORD, Conn. , Nov. 5, 2025 /PRNewswire/ — Naples…
AMA assigns CPT codes 0992T and 0993T to Caristo’s CaRi-Heart® AI-powered analysis of perivascular fat and cardiovascular risk, which are included in the 2026 CPT® Codebook New CPT codes mark a major step toward making CaRi-Heart technology available in everyday clinical care in the U.S….
‘FORTIFY’ Selects FAI-Score™ as Primary Outcome Measure, and Caristo as Worldwide Imaging Core Lab for Coronary Inflammation and Plaque Measurement and Monitoring STAMFORD, Conn. and LOS ANGELES, Sept. 16, 2025 /PRNewswire/ — Caristo Diagnostics, on a mission to transform the diagnosis…
FAI-Score has stronger predictive value than hsCRP for 10-year cardiac death, even among those with zero calcium score and no visible coronary plaque In patients with low hsCRP, high FAI-Score predicts 7-fold higher risk of cardiac death OXFORD, England, Sept. 11, 2025 /PRNewswire/ –…
New data shows CaRi-Heart FAI-Score technology predicts cardiac risk—even in patients with low or zero calcium scores, traditionally considered low-risk CaRi-Heart results from large-scale implementation at five National Health Service (NHS) hospitals in the UK will be presented STAMFORD,…
New CPT codes mark a major step toward making Caristo’s CaRi-Heart®—the first AI-powered tool to detect coronary inflammation from routine CT scans—available in everyday clinical care Rewriting the rules of cardiac risk assessment, Caristo moves beyond anatomy to reveal the biological…
FDA 510(k) clearance of Caristo’s CaRi-Plaque™ technology advances AI innovator’s U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinics The CaRi-Plaque technology delivers AI-driven precision in coronary plaque detection, helping cardiologists…
Seasoned MedTech, Biotech and Digital Health leader and entrepreneur brings business and operational insights to fast-growing digital diagnostics company OXFORD, England, Feb. 18, 2025 /PRNewswire/ — Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk…
Company also named a Finalist in the Fierce Healthcare Innovation Awards OXFORD, England, Oct. 23, 2024 /PRNewswire/ — Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, has been selected a winner of the Digital Health Hub Foundation: Digital…
OXFORD, England, Sept. 3, 2024 /PRNewswire/ — Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, has been selected as a quarterfinalist for the prestigious Digital Health Hub Foundation: Digital Health Awards. Caristo was chosen as a…
